In liver cancer, NR6A1 has been reported to be a novel regulator of lipogenesis in HepG2 cells, and NR6A1 knockdown can increase lipid accumulation as well as insulin-induced proliferation and migration of HepG2 cells [19]. This evidence concerns the gene NR6A1 and liver cancer.